JP Morgan Chase
AURA icon

JP Morgan Chase’s Aura Biosciences AURA Stock Holding History

JP Morgan Chase’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$188K Buy
27,382
+3,847
+16% +$27.5K ﹤0.01% 5656
2026
Q1 		$146K Buy
23,535
+416
+2% +$2.39K ﹤0.01% 5637
2025
Q4 		$126K Sell
23,119
-1,438
-6% -$8.54K ﹤0.01% 5765
2025
Q3 		$152K Buy
24,557
+2,693
+12% +$17.6K ﹤0.01% 5667
2025
Q2 		$137K Sell
21,864
-4,259
-16% -$24.9K ﹤0.01% 5453
2025
Q1 		$153K Sell
26,123
-68,263
-72% -$516K ﹤0.01% 5366
2024
Q4 		$776K Buy
94,386
+40,884
+76% +$385K ﹤0.01% 4794
2024
Q3 		$477K Buy
53,502
+27,718
+108% +$238K ﹤0.01% 4922
2024
Q2 		$195K Buy
25,784
+1,499
+6% +$11K ﹤0.01% 5176
2024
Q1 		$191K Buy
24,285
+5,925
+32% +$49.1K ﹤0.01% 5381
2023
Q4 		$163K Sell
18,360
-281
-2% -$2.38K ﹤0.01% 5498
2023
Q3 		$167K Sell
18,641
-3,030
-14% -$32.6K ﹤0.01% 5176
2023
Q2 		$268K Buy
21,671
+3,173
+17% +$33.9K ﹤0.01% 4896
2023
Q1 		$171K Buy
18,498
+7,752
+72% +$80.5K ﹤0.01% 5148
2022
Q4 		$113K Buy
10,746
+733
+7% +$9.33K ﹤0.01% 5306
2022
Q3 		$181K Buy
10,013
+215
+2% +$3.25K ﹤0.01% 5005
2022
Q2 		$139K Buy
9,798
+7,170
+273% +$119K ﹤0.01% 5246
2022
Q1 		$58K Sell
2,628
-3,967
-60% -$75.6K ﹤0.01% 5735
2021
Q4 		$112K Buy
+6,595
New +$118K ﹤0.01% 5621

Other funds holding AURA

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

JP Morgan Chase's AURA Position: Q2 2026 in Review

JP Morgan Chase increased its Aura Biosciences (AURA) stake by 16% in Q2 2026, buying an estimated $27.5K and bringing the position to 27,382 shares worth $188K. The position accounts for ﹤0.01% of the portfolio, ranked #5656.

JP Morgan Chase first reported a position in AURA in Q4 2021 and has held it in 19 quarters since. The position peaked at $776K in Q4 2024. 147 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • JP Morgan Chase held 27,382 shares of Aura Biosciences worth $188K as of Q2 2026.
  • JP Morgan Chase bought 3,847 Aura Biosciences shares in Q2 2026, an estimated $27.5K.
  • Aura Biosciences made up ﹤0.01% of JP Morgan Chase's portfolio in Q2 2026, its #5656 holding.
  • JP Morgan Chase first reported a position in Aura Biosciences in Q4 2021 and has held it in 19 quarters since.
  • JP Morgan Chase's Aura Biosciences position peaked at $776K in Q4 2024.
  • 147 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on JP Morgan Chase's 13F filing for Q2 2026, filed 12 Aug 2026.